A case control investigation of COVID-19 associated Mucormycosis in India

Author:

Anand Tanu1,Mukherjee Aparna1,Satija Aanchal1,Velamuri Poonam Sharma1,Singh Kh. Jitenkumar2,Das Madhuchhanda1,Josten Kripa1,Yadav Pragya D.3,Sahay Rima R.3,Keche Archana Y4,Nagarkar Nitin M4,Gupta Prashant5,Reddy D. Himanshu5,Mistry Sejal N.6,Patel Jimy D.6,Rao Prajwal7,Rohatgi Shalesh7,Ghosh Soumitra8,Hazra Avijit8,Kindo Anupma Jyoti9,Annamalai Radha9,Rudramurthy Shivaprakash M10,Singh Mini P10,Shameem Mohammad11,Fatima Nazish11,Khambholja Janakkumar R.12,Parikh Sangita13,Madkaikar Manisha14,Pradhan Vandana D.14,Kataria Sushila15,Sharma Pooja15,Panda Samiran1,group ICMR- Mucormycosis group ICMR-Mucormycosis

Affiliation:

1. Indian Council of Medical Research

2. National Institute of Medical Statistics

3. ICMR-National Institute of Virology

4. All India Institute of Medical Sciences Raipur

5. King George's Medical University

6. Pandit Dindayal Upadhyay Medical College

7. Dr. D. Y. Patil Medical College, Hospital and Research Centre

8. Institute of Post Graduate Medical Education and Research

9. Sri Ramachandra Institute of Higher Education and Research

10. Post Graduate Institute of Medical Education and Research

11. Jawaharlal Nehru Medical College Aligarh Muslim University

12. Smt. N.H.L. Municipal Medical College

13. AMC MET Medical College

14. ICMR-NIIH

15. Medanta The Medicity

Abstract

Abstract Background: Increased occurrence of mucormycosis in India during the second wave of the COVID-19 pandemic in early 2021 in India subsequently prompted us to undertake a multi-site case-control investigation. The objectives were to examine the monthly trend of Covid-19 Associated Mucormycosis (CAM) cases among in-patients and to identify factors associated with it.Methods: Eleven study sites were involved across India and archived records since 1st January till 30th September, 2021 were used for trend analysis. The cases and controls were enrolled during 15th June 2021 to 30th September 2021. Data were collected using a semi-structured questionnaire. Among 1211 enrolled participants, 336 were CAM cases and 875 were COVID-19 positive non-mucormycosis controls. Results: Admitted CAM-case number reached highest point in May 2021 after a month of peak admission for COVID-19. Odds of developing CAM increased with the history of working in a dusty environment (adjusted odds ratio; aOR 3.24, 95%CI: 1.34, 7.82), diabetes mellitus (aOR: 31.83, 95%CI: 13.96, 72.63), longer duration of hospital stay (aOR: 1.06, 95%CI: 1.02, 1.11) and use of methyl prednisolone (aOR: 2.71, 95%CI: 1.37, 5.37) following adjustment for age, gender, occupation, education, type of houses used for living, requirement of ventilatory support and route of steroid administration. Higher proportion of CAM cases required supplemental oxygen compared to the controls; use of non-rebreather mask (NRBM) was associated as a protective factor against mucormycosis compared to face masks (aOR: 0.18, 95%CI: 0.08, 0.41). Genomic sequencing of archived respiratory samples showed similar presence of Delta and Delta derivates in both cases and controls.Conclusions: Appropriate management of hyperglycemia, judicious use of steroids and use of NRBM during oxygen supplementation among COVID-19 patients bear the potential to reduce the risk of occurrence of mucormycosis. Avoiding exposure to dusty environment would add to prevention efforts.

Publisher

Research Square Platform LLC

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3